Recently, to examine stroke gene therapy in the acute phase [10] and preventive [11] treatment in a rat model, we employed human umbilical cord blood mononuclear cells (UCB-MC) for the tandem delivery of three therapeutic genes encoding VEGF, GDNF, and the neural cell adhesion molecule (NCAM). Here, VEGFA is linked to stroke disorder.